These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2473408)

  • 1. Modulation of [3H]DAGO binding by substance P (SP) and SP fragments in the mouse brain and spinal cord via MU1 interactions.
    Krumins SA; Kim DC; Seybold VS; Larson AA
    Neuropeptides; 1989; 13(4):225-33. PubMed ID: 2473408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance P modulation of DAMGO binding in the brain of CXBK and Swiss-Webster mice.
    Krumins SA; Kim DC; Larson AA
    Peptides; 1990; 11(2):281-5. PubMed ID: 1694028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception.
    Liu-Chen LY; Li SX; Wheeler-Aceto H; Cowan A
    Eur J Pharmacol; 1991 Oct; 203(2):195-202. PubMed ID: 1666046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific binding of substance P aminoterminal heptapeptide [SP(1-7)] to mouse brain and spinal cord membranes.
    Igwe OJ; Kim DC; Seybold VS; Larson AA
    J Neurosci; 1990 Nov; 10(11):3653-63. PubMed ID: 1700082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance P modulation of [3H]DAGO binding in the brain of Swiss-Webster and CXBK (mu opioid receptor deficient) mice.
    Krumins SA; Kim DC; Larson AA
    Prog Clin Biol Res; 1990; 328():149-52. PubMed ID: 1689493
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DAMGO binding to mouse brain membranes: influence of salts, guanine nucleotides, substance P, and substance P fragments.
    Krumins SA; Kim DC; Igwe OJ; Larson AA
    Peptides; 1993; 14(2):309-14. PubMed ID: 7683401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid ligand binding sites in the spinal cord of the guinea-pig.
    Zarr GD; Werling LL; Brown SR; Cox BM
    Neuropharmacology; 1986 May; 25(5):471-80. PubMed ID: 3016586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoradiographic evidence for two classes of mu opioid binding sites in rat brain using [125I]FK33824.
    Rothman RB; Jacobson AE; Rice KC; Herkenham M
    Peptides; 1987; 8(6):1015-21. PubMed ID: 2831515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment of rats with the irreversible mu-receptor antagonist, beta-FNA, fails to prevent naltrexone-induced upregulation of mu-opioid receptors.
    Rothman RB; Long JB; Bykov V; Jacobson AE; Rice KC; Holaday JW
    Neuropharmacology; 1990 Sep; 29(9):805-10. PubMed ID: 1963479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding in vivo of selective mu and delta opioid receptor agonists: opioid receptor occupancy by endogenous enkephalins.
    Meucci E; Delay-Goyet P; Roques BP; Zajac JM
    Eur J Pharmacol; 1989 Nov; 171(2-3):167-78. PubMed ID: 2559856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effects of delta and mu opioid receptor agonists on the in vitro release of substance P-like material from the rat spinal cord.
    Mauborgne A; Lutz O; Legrand JC; Hamon M; Cesselin F
    J Neurochem; 1987 Feb; 48(2):529-37. PubMed ID: 2432185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kappa-/mu-receptor interactions in the opioid control of the in vivo release of substance P-like material from the rat spinal cord.
    Collin E; Mauborgne A; Bourgoin S; Mantelet S; Ferhat L; Hamon M; Cesselin F
    Neuroscience; 1992 Nov; 51(2):347-55. PubMed ID: 1281527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of morphine tolerance and abstinence on the binding of [3H]naltrexone to discrete brain regions and spinal cord of the rat.
    Reddy PL; Veeranna ; Matwyshyn GA; Thorat SN; Bhargava HN
    Gen Pharmacol; 1994 Mar; 25(2):355-61. PubMed ID: 8026736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo determination of opiate antagonist binding at mu-opioid ([3H]-DAGO) receptors in hypothalamic micropunches from maturing female rats: comparison between SDZ 210-096 and nalmefene.
    Landymore KM; Giles A; Wilkinson M
    Neuropeptides; 1992 Mar; 21(3):175-82. PubMed ID: 1321363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profiles of fentanyl analogs at mu, delta and kappa opiate receptors.
    Maguire P; Tsai N; Kamal J; Cometta-Morini C; Upton C; Loew G
    Eur J Pharmacol; 1992 Mar; 213(2):219-25. PubMed ID: 1355735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]ohmefentanyl preferentially binds to mu-opioid receptors but also labels sigma-sites in rat brain sections.
    Wang H; Pélaprat D; Roques BP; Vanhove A; Chi ZQ; Rostène W
    Eur J Pharmacol; 1991 Feb; 193(3):341-50. PubMed ID: 1647320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
    Heyman JS; Mulvaney SA; Mosberg HI; Porreca F
    Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta receptor involvement in morphine suppression of noxiously evoked activity of spinal WDR neurons in cats.
    Omote K; Kitahata LM; Nakatani K; Collins JG
    Brain Res; 1991 Jul; 554(1-2):299-303. PubMed ID: 1657291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.